Latest Administration News

Page 21 of 184
Memphasys Limited (ASX: MEM) announced an investor webinar and released an updated presentation detailing its transition from early-stage commercialisation to scaling global revenues, highlighting multi-market sales, recurring cartridge revenue, and regulatory progress.
Ada Torres
Ada Torres
7 Apr 2026
Radiopharm Theranostics has secured a clinical supply agreement with Siemens Healthineers to manufacture and distribute RAD101, advancing its Phase 3 trial in the U.S. Interim Phase 2b data showed 90% concordance with MRI in detecting brain metastases.
Ada Torres
Ada Torres
7 Apr 2026
Telix Pharmaceuticals posted an 11% increase in Q1 2026 revenue to US$230 million, reaffirmed full-year guidance, and reported progress in multiple clinical trials including its lead prostate cancer therapy TLX591-Tx.
Ada Torres
Ada Torres
7 Apr 2026
Tesoro Gold has issued a replacement Appendix 5B for the December 2025 quarter to correct an administrative error and reclassify certain deposits, ensuring consistency with its audited FY2025 financial statements.
Maxwell Dee
Maxwell Dee
2 Apr 2026
Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.
Victor Sage
Victor Sage
2 Apr 2026
CVC Limited has addressed ASX concerns over a delayed Appendix 3Y filing related to director John Leaver’s interest change, attributing the delay to administrative oversight while affirming existing compliance policies.
Claire Turing
Claire Turing
1 Apr 2026
Dome Gold Mines Ltd launches a $3 million convertible note offering to fund key developments in Fiji, including the Sigatoka Feasibility Study and expanded exploration for copper, gold, and silver.
Maxwell Dee
Maxwell Dee
1 Apr 2026
Lumos Diagnostics has secured its largest-ever order for FebriDx® following FDA clearance, signalling a major expansion in the US market opportunity.
Ada Torres
Ada Torres
1 Apr 2026
AdAlta’s BZDS1901 CAR-T therapy shows remarkable tumour shrinkage and complete responses in advanced mesothelioma patients, doubling expected outcomes and paving the way for higher dosing and expanded trials.
Ada Torres
Ada Torres
1 Apr 2026
Haranga Resources is set to launch a 4,000-metre reverse circulation drilling program at its Ibel South Gold Project in Senegal, aiming to extend high-grade gold mineralisation at depth and explore fresh anomalies identified by termite mound sampling.
Maxwell Dee
Maxwell Dee
1 Apr 2026
Andromeda Metals faces uncertainty in securing cornerstone funding for its Great White Project due to Middle East geopolitical tensions, while pushing forward with its High Purity Alumina pilot plant commissioning.
Maxwell Dee
Maxwell Dee
31 Mar 2026
Optiscan Imaging Ltd has taken a significant step towards commercialising its InSpecta® veterinary imaging device in the US by submitting a regulatory dossier to the FDA. This milestone not only initiates formal review but also sets the stage for broader clinical adoption and future device approvals.
Ada Torres
Ada Torres
31 Mar 2026